BioLargo, Inc.
BLGOOTCBasic Materials● Active
$0.15
+$0.03(+30.00%)
Market Cap$47972009
P/E Ratio—
52W High$0.23
52W Low$0.1
BioLargo, Inc. (BLGO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BLGO · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $7.76M | $17.78M | $12.23M | $5.88M | $2.53M |
| Cost of Revenue | $4.36M | $9.93M | $6.08M | $3.03M | $1.43M |
| Gross Profit | $3.41M | $7.85M | $6.15M | $2.86M | $1.10M |
| Gross Margin %(computed) | 43.86% | 44.17% | 50.32% | 48.56% | 43.58% |
| Operating Expenses | |||||
| R&D Expenses | $2.59M | $2.88M | $2.28M | $1.32M | $1.37M |
| G&A Expenses | $0.00M | $8.81M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $18.25M | $12.18M | $10.34M | $7.98M | $7.48M |
| Operating Income | ($14.84M) | ($4.33M) | ($4.19M) | ($5.12M) | ($6.38M) |
| Operating Margin %(computed) | -191.13% | -24.36% | -34.23% | -87.00% | -252.11% |
| Interest Income | $0.20M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.54M | $0.14M | $0.09M | $0.05M | $0.23M |
| Income Before Tax | ($15.19M) | ($2.40M) | ($4.63M) | ($5.13M) | ($6.89M) |
| Income Tax Expense | $0.00M | $1.95M | $0.01M | $0.00M | $0.00M |
| Net Income | ($11.78M) | ($2.40M) | ($3.50M) | ($4.50M) | ($7.38M) |
| Net Margin %(computed) | -151.71% | -13.51% | -28.65% | -76.41% | -291.47% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.04 | $-0.01 | $-0.01 | $-0.02 | $-0.03 |
| Wtd Avg Shares | 306.95M | 298.12M | 285.96M | 268.30M | 247.20M |
| EBITDA | ($14.55M) | ($4.06M) | ($4.19M) | ($5.10M) | ($6.70M) |
| EBITDA Margin %(computed) | -187.35% | -22.83% | -34.23% | -86.62% | -264.84% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more BioLargo, Inc. data
About BioLargo, Inc. (BLGO) Income Statement
BioLargo, Inc. (BLGO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BLGO reported revenue of $0.01B, gross profit of $0.00B (gross margin 43.86%), and net income of ($0.01B) — a net profit margin of -151.71%.
Frequently asked questions
BLGO · 4 questionsBioLargo, Inc. (BLGO) reported revenue of $0.01B for 2025, down 56.3% year-over-year.
BLGO revenueBLGO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09